Total Payments
$329,678
2021 Payments
$206,845
Companies
1
Transactions
22
Payment Breakdown by Category
Other$327,392 (99.3%)
Consulting$2,255 (0.7%)
Food & Beverage$31.44 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $327,392 | 16 | 99.3% |
| Consulting Fee | $2,255 | 5 | 0.7% |
| Food and Beverage | $31.44 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $329,678 | 22 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $206,845 | 16 | Pacira Pharmaceuticals Incorporated ($206,845) |
| 2020 | $122,833 | 6 | Pacira Pharmaceuticals Incorporated ($122,833) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/01/2021 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $20,455.85 | General |
| Category: Pain Management | ||||||
| 06/03/2021 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Consulting Fee | Cash or cash equivalent | $165.00 | General |
| Category: Pain Management | ||||||
| 06/01/2021 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $20,455.85 | General |
| Category: Pain Management | ||||||
| 05/17/2021 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $31.44 | General |
| Category: Pain Management | ||||||
| 05/01/2021 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $20,455.85 | General |
| Category: Pain Management | ||||||
| 04/29/2021 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Consulting Fee | Cash or cash equivalent | $220.00 | General |
| Category: Pain Management | ||||||
| 04/01/2021 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $20,455.85 | General |
| Category: Pain Management | ||||||
| 03/23/2021 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| Category: Pain Management | ||||||
| 03/02/2021 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $20,455.85 | General |
| Category: Pain Management | ||||||
| 03/02/2021 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Consulting Fee | Cash or cash equivalent | $1,210.00 | General |
| Category: Pain Management | ||||||
| 03/01/2021 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $20,455.85 | General |
| Category: Pain Management | ||||||
| 02/02/2021 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $20,455.85 | General |
| Category: Pain Management | ||||||
| 02/01/2021 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $20,455.85 | General |
| Category: Pain Management | ||||||
| 01/20/2021 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Consulting Fee | Cash or cash equivalent | $110.00 | General |
| Category: Pain Management | ||||||
| 01/02/2021 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $20,455.85 | General |
| Category: Pain Management | ||||||
| 01/01/2021 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $20,455.85 | General |
| Category: Pain Management | ||||||
| 12/02/2020 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $20,455.85 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/02/2020 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $20,455.85 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/02/2020 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $20,480.40 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/02/2020 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $20,480.40 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/02/2020 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $20,480.40 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/02/2020 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | In-kind items and services | $20,480.40 | General |
| Category: PAIN MANAGEMENT | ||||||
About Dr. Gerald Maccioli, MD
Dr. Gerald Maccioli, MD is a Anesthesiology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104937085.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerald Maccioli, MD has received a total of $329,678 in payments from pharmaceutical and medical device companies, with $206,845 received in 2021. These payments were reported across 22 transactions from 1 company. The most common payment nature is "Current or prospective ownership or investment interest" ($327,392).
Ad
Practice Information
- Specialty Anesthesiology
- Other Specialties Critical Care Medicine
- Location Raleigh, NC
- Active Since 08/31/2006
- Last Updated 04/03/2015
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1104937085
Products in Payments
- Exparel (Drug) $206,845
- EXPAREL (Drug) $122,833
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Raleigh
Dr. Marc Yelle, Md Phd, MD PHD
Anesthesiology — Payments: $33,152
Anesthesiology $33,152
Dr. Paul Carnes, M.d, M.D
Anesthesiology — Payments: $16,641
Anesthesiology $16,641
Dr. Jack Lam, Md, MD
Anesthesiology — Payments: $7,948
Anesthesiology $7,948
Dr. Kevin Vorenkamp, M.d, M.D
Anesthesiology — Payments: $3,297
Anesthesiology $3,297
Robert Jacobson, Md, MD
Anesthesiology — Payments: $2,232
Anesthesiology $2,232
Duran Mitchell, M.d, M.D
Anesthesiology — Payments: $2,029
Anesthesiology $2,029